Introduction {#s1}
============

Charcot-Marie-Tooth disease (CMT), also known as hereditary motor and sensory neuropathy or peroneal muscular atrophy, is a genetically and clinically heterogeneous group of inherited neuropathies ([@B1]). Clinically, it is characterized by progressive muscle weakness and atrophy, and distal sensory loss ([@B2]). X-linked CMT (CMTX1) is the second most common form of CMT, and it is caused by *gap junction protein beta-1* (*GJB1*, also known as *Cx32*) gene mutations. The phenotype of CMTX1 is typically characterized by a mixture of demyelinating and axonal features ([@B3]).

Transient central nervous system deficits associated with white matter abnormalities on magnetic resonance imaging (MRI) have been reported in patients with CMTX1 ([@B4], [@B5]). Electrophysiological examination plays an important role in diagnosis of CMTX1, particularly when there is a need to differentiate it from the diagnosis of stroke-like acute onset neurological deficits with white matter lesions ([@B6]) or episodic acute demyelinating encephalomyelitis (ADEM)-like illness ([@B7]). However, electrophysiological assessment in CMTX1 with transient central nervous system deficits is rare, and thus the electophysiological features are seldom reported.

Here we report a large series of CMTX1 patients with transient central nervous system deficits who had electrophysiological examination. We reviewed and analyzed the published reports with a primary goal of determining the electrophysiological features of CMTX1 patients with transient central nervous system deficits and discussing aids in diagnosis.

Methods {#s2}
=======

Search strategy and study screening
-----------------------------------

A systematic literature search was conducted on March 21, 2018 on PubMed (from January 1966) and Embase databases (from 1947). Key search terms used were: Charcot-Marie-Tooth, X-linked, gap junction or GJB1 or connexin, white matter or encephalomyel^\*^ or central nervous or leukoencephal^\*^, electrophysiol^\*^ OR electromyo^\*^ OR EMG OR motor nerve conduction velocity (MNCV) OR distal motor latencies OR compound muscle action potential (CMAP). A manual search of relevant review papers was also performed.

The current investigation was performed and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines ([@B8]). All citations and selected articles were read in full and rated on quality by two independent reviewers (Wen and Yang).

Inclusion criteria, and exclusion criteria
------------------------------------------

The inclusion criteria were as follows: (1) X-linked Charcot-Marie-Tooth with transient central nervous system deficits; (2) electrophysiological examination was performed; (3) case report or case series. The exclusion criteria were as follows: (1) no adequate data reported or obtained by contacting the authors; (2) duplicate publications.

Data extraction
---------------

Search strategy and study selection are presented in Figure [1](#F1){ref-type="fig"}. A data extraction sheet was used to record study and patient demographic variables; family history; genetic mutation; and clinical, MRI and electrophysiological findings. Data were extracted and verified by two investigators (Wen and Cao).

![Flowchart of search strategy and study selection.](fneur-09-00461-g0001){#F1}

Statistical analysis
--------------------

Statistical analysis was performed with GraphPad Prism 5 software (GraphPad Software Inc., La Jolla, CA) and SPSS Statistics 13 (SPSS Corporation, Chicago, IL). The continuous variables are presented as means with 95% confidence intervals (CI). A two-tailed comparison with *P* \< 0.05 was considered statistically significant. Differences between groups were analyzed by the independent sample *t*-test or the Mann-Whitney *U*-test (for nonparametric comparisons), for the continuous variables.

Results {#s3}
=======

Search results and demographic characteristics
----------------------------------------------

A total of 21 CMTX1 patients with transient central nervous system deficits were found in 17 case reports/series published between 2001 and 2016 ([@B4]--[@B7], [@B9]--[@B21]). Demographic, clinical, MRI, genetic, and electrophysiological data of 21 cases from the literature were reviewed (see Tables [1](#T1){ref-type="table"}--[3](#T3){ref-type="table"}, Supplement Table [1](#SM1){ref-type="supplementary-material"}).

###### 

Demographic characteristics, family history, and mutation in CMTX1 with transient central nervous system deficits.

  **No. of patient**   **Year**   **Country**   **Age at onset**   **Age at examination**   **Family history**              **Diagnosis of families**                               **Nucleotide transition**   **Amino acid substitution**   **References**
  -------------------- ---------- ------------- ------------------ ------------------------ ------------------------------- ------------------------------------------------------- --------------------------- ----------------------------- -------------------------
  1                    2001       Greece        10                 21                       Brother, mother                 Brother, same disease; Mother, asymptomatic pes cavus   C164T                       Thr55Ile                      Panas et al. [@B5]
  2                    2001       Greece        12                 19                       Brother, mother                 Brother, same disease; Mother, asymptomatic pes cavus   C164T                       Thr55Ile                      Panas et al. [@B5]
  3                    2003       Germany       10                 12                       Brother, mother                 Brother, same disease; Mother, CMTX                     304-306delGAG                                             Hanemann et al. [@B9]
  4                    2003       Germany       0.5                19                       Brother, mother                 Brother, same disease; Mother, CMTX                     304-306delGAG                                             Hanemann et al. [@B9]
  5                    2010       Italy         14                 14                       Mother                          CMT                                                     G164A                       Arg164Gln                     Fusco et al. [@B10]
  6                    2011       Japan         13                 15                       Mother                          CMT                                                     397delT                                                   Sakaguchi et al. [@B11]
  7                    2012       China         14                 17                       Maternal grandfather            CMT                                                                                 Asn54Ser                      Zhong et al. [@B12]
  8                    2014       Korea         14                 14                       Mother                          Asymptomatic pes cavus                                  G3T                         Met1Ile                       Kim et al. [@B7]
  9                    2014       Italy         16                 29                       Mother                          clinical CMT                                            297_298insCAA               Gln99_His100inGln             Sagnelli et al. [@B13]
  10                   2014       China         15                 15                       Mother                          Asymptomatic pes cavus                                  T278G                                                     Zhao et al. [@B14]
  11                   2014       USA           12                 12                       Mother                          Asymptomatic pes cavus                                  T98A                        Ile33Asn                      McKinney et al. [@B15]
  12                   2015       USA           13                 20                       Mother and maternal relatives   CMT                                                     T467G                       Leu156Ala                     Wu et al. [@B6]
  13                   2015       India         8                  19                       Brother, mother                 CMT                                                     G425A                       Arg142Gln                     Kulkarni et al. [@B16]
  14                   2016       China         18                 24                       Maternal grandfather            CMTX                                                    T445C                       Pro149Leu                     Xie et al. [@B17]
  15                   2002       Netherlands   10                 14                       Mother                          CMT                                                     C\>T                        Arg164Trp                     Schelhaas et al. [@B18]
  16                   2008       USA           13                 15                       Brother, mother                 CMTX                                                                                Val139Met                     Halbrich et al. [@B19]
  17                   2008       USA           15                 16                       Brother, mother                 CMTX                                                                                Val139Met                     Halbrich et al. [@B19]
  18                   2010       USA           10                 10                       Maternal grandmother            CMT                                                     codon 22                    Arg22Glu                      Rosser et al. [@B20]
  19                   2011       Canada        11                 11                       Mother                          CMT                                                     196G196A                    Asn66Asn                      U-King-Im et al. [@B21]
  20                   2013       USA           14                 14                       NA                              NA                                                      C260G                       Pro87Leu                      Al-Mateen et al. [@B4]
  21                   2013       USA           10                 17                       Mother                          CMT                                                     G477A                       Val139Met                     Al-Mateen et al. [@B4]

*CMTX, X-linked Charcot-Marie-Tooth disease*.

Demographic characteristics, family history, and mutation
---------------------------------------------------------

Demographic characteristics, family history, and mutation in CMTX1 with transient central nervous system deficits are shown in Table [1](#T1){ref-type="table"}. The age of CNS disturbance onset ranged from 0.5 to 18 years old with a mean of 12.02 ± 0.78 years. The age range of examination was 10--29 years old, with a mean ± standard deviation (SD) of 16.52 ± 0.99 years. All patients were male. Seven patients were from Europe, six from Asia, and eight from North America. Family histories were found in all cases. Two brothers were reported as CMTX1 with transient central nervous system deficits with the same mutation in *GJB1* gene in 3 families. All the other families had proband\'s mother or maternal relatives with CMT or asymptomatic pes cavus.

Clinical and MRI features
-------------------------

Clinical and MRI features in CMTX1 with transient central nervous system deficits are shown in Table [2](#T2){ref-type="table"}. Recurrent episodes of the central nervous system deficits were reported in all 21 cases and resolved in periods ranging from several minutes to 3 days. All 21 patients (100%) had transient weakness of limbs, 17 patients (80.95%) had transient dysarthria (10/21), dysphagia (3/21), or both (4/21); 6 patients (28.57%) had numbness, and 2 patients (9.52%) had ataxia. The transient central nervous system deficits presented after a fever in 9 cases (42.86%), exercise in 4 patients (19.05%), travel to high altitude in 2 patients (9.52%), and vomiting and diarrhea in 1 patient (4.76%). All 20 patients who had MRI at presentation had bilateral abnormal T2/Diffusion signal in the white matter. The other patients without MRI presented with recurrent episodes of transient neurological dysfunction on two consecutive days. Investigations included normal results for brain computed tomography (CT) scan, CT angiogram, lumber puncture (*n* = 19, Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}).

###### 

clinical and MRI features in CMTX1 with transient central nervous system deficits.

  **No. of patient**   **Limb weakness**                **Dysarthria/ dysphagia**   **Numbness**   **Ataxia**   **Predisposing factor(s)**   **Duration to recovery**    **Clinical characteristics**   **Bilaterally symmetric white matter lesions on MRI**   **Enhancement**   **MRI improvement**   **Time of MRI follow-up**
  -------------------- -------------------------------- --------------------------- -------------- ------------ ---------------------------- --------------------------- ------------------------------ ------------------------------------------------------- ----------------- --------------------- ---------------------------
  1                    Weakness of limbs                Dysarthria, dysphagia                                                                5 h to 3 days               Recurrent episode              Yes                                                     NA                NA                    NA
  2                    Weakness of limbs                                                                                                                                 Recurrent episode              Yes                                                     NA                NA                    NA
  3                    Weakness of limb                 Dysarthria, dysphagia                                   Exercise, high altitude      1, 3 h                      Recurrent episode              Yes                                                     no                Yes                   3 months
  4                    Weakness of limb                 Dysarthria, dysphagia                                   Fever                        1, 24 h                     Recurrent episode              Yes                                                     no                Yes                   6 months
  5                    Weakness of limbs                Dysarthria                  Numbness       Ataxia       Fever                        12--24 h                    Recurrent episode              Yes                                                     NA                Yes                   2 months
  6                    Paresis of left arm              Dysphagia                   Numbness                    Vomiting and diarrhea        3 h                         Recurrent episode              Yes                                                     NA                Yes                   11 days
  7                    Right hemiparesis                Dysarthria                                              Fever                        5--7 h                      Recurrent episode              Yes                                                                       Yes                   3 months
  8                    Weakness of limbs                Dysarthria                                                                           I h                         Recurrent                      Yes                                                     No                NA                    NA
  9                    Right hemiparesis                                                                        Exercise                     2 h                         Recurrent                      Yes                                                     NA                Yes                   18 months
  10                   Weakness of limbs                Dysphagia                                               Exercise, fever              2 h                         Recurrent                      Yes                                                     ND                Yes                   2 months
  11                   Left arm weakness                Dysphonia, Dysphagia                                                                 3 days                      Recurrent, episode             Yes                                                     No                Yes                   2 months
  12                   Left facial weakness             Dysarthria                  Numbness                                                 3 h                         Recurrent, episode             Yes                                                     No                Yes                   3 months
  13                   Weakness of limbs                Dysarthria                  Numbness                                                 20, 30 min and 10 h         Recurrent episodes             Yes                                                     NA                Yes                   1 month
  14                   Weakness of limbs                Dysarthria                                                                           4 h                         Recurrent episodes             Yes                                                     no                Yes                   2 months
  15                   Weakness of both limbs           Dysarthria, dysphagia                                                                6 h                         Recurrent episode              Yes                                                                       Yes                   2 months
  16                   Weakness of limbs                Dysarthria                                              Fever                        8 h                         Recurrent episode              ND                                                      ND                NA                    NA
  17                   Weakness of limbs                Dysarthria                                              Fever                        4 h                         Recurrent episode              Yes                                                     no                Yes                   3 months
  18                   Right upper extremity weakness                               Numbness       Ataxia                                    3 h                         Recurrent episode              Yes                                                     No                Yes                   6 months
  19                   Weakness of right upper limb     Aphasia                                                 Fever                        2.5 h                       Episode                        Yes                                                     Yes               Yes                   3 months
  20                   Right hand weakness                                          Numbness                    High altitude, fever         6h-3days                    Recurrent                      Yes                                                     No                Yes                   2 months
  21                   Weakness of limbs                Dysarthria                                              Fever                        Several min, 90 min, 12 h   Recurrent episode              Yes                                                     No                Yes                   2 months

*CMTX, X-linked Charcot-Marie-Tooth disease*.

All 11 cases with administration of gadolinium during the brain MRI reported no enhancement. Subsequent MRI results in 17 cases were within normal limits or showed improvement. The follow-up MRIs were performed from 11 days to 18 months after the episode of the disease, median 2 months.

Electrophysiological features
-----------------------------

Of the 21 electrophysiological examinations, 14 cases had detectable electrophysiological parameters, and 7 cases had normal laboratory values ([@B9]--[@B12], [@B14], [@B15]). Supplementary Table [1](#SM1){ref-type="supplementary-material"} summarizes 21 electrophysiological examinations in CMTX1 patients with transient central nervous system deficits. The changes in electrophysiological parameters were compared with the normal values, and the variation with respect to normal values is shown in Table [3](#T3){ref-type="table"}.

###### 

Variations of electrophysiological examination in CMTX1 with transient central nervous system deficits.

  **No. of patient**   **Median nerve**   **Ulnar nerve**   **Peroneal nerve**   **Tibial nerve**   **Sural nerve**                                                                                                                                                       
  -------------------- ------------------ ----------------- -------------------- ------------------ ----------------- -------- -------- -------------- -------------- -------------- -------------- ------------ -------------- -------- -------- -------------- -------- --------------
  3                                                                                                                                                                                                                             Normal            −27            −66.7    
  4                                                                                                                                                                                                                             Normal            −28.6          Normal   
  5                    −60                +100              −22.2                −33.3              −20                                                −50            −24.4          −20            +25          −17.5          −6       +50      −17.5                   
  6                    −80.3              +26.1             −25.5                −71.4              −15.1             −58      Normal   −25.9          −55.1          −12.2          −98            +1.5         −27.9          −87.2    +19.3    −14.9          −54.1    −19.2
  7                    −86.7              +231              −10                  −26.1                                −86.7    +171     −8             −58.7                         −96.2          +540         −32.2          −85.6    +586     −44.2                   
  10                   −92                +40               −38                  −92                −42               Normal   Normal   −49            −89            −39                                                       −98      Normal                           
  11                   −71.4              +25               −23.3                Normal             −2.5                                                                                                                        −34.5    +13.3    −31.5          −47      −27.1
  Average              −78.1 ± 5.68       +84.5 ± 39.2      −22.0 ± 5.96                            −19.9 ± 8.24                        −27.6 ± 11.9   −63.2 ± 8.78   −25.2 ± 7.75   −71.4 ± 25.7   +189 ± 176   −25.9 ± 4.36                     −27.3 ± 4.30            −23.2 ± 3.95

*CMTX, X-linked Charcot-Marie-Tooth disease; CMAP, compound muscle action potential; MNCV, median motor nerve conduction velocity; SNAP, sensory nerve action potential (SNAP); SNCV, sensory nerve conduction velocity*.

All nerve conduction examinations performed at presentation showed marked slowing of conduction velocity. The median MNCV, CMAP amplitude, and motor latencies were the most commonly measurable electrophysiological parameters (85.7%). Median MNCVs were all below the normal value, and mean ± SD MNCVs of the 12 cases were 37.7 ± 1.22 m/s (range 32--48.5 m/s).

All cases that had MNCV at presentation had slower and significantly decreased MNCV compared with the normal value (34.1 ± 1.10 m/s vs. 46.8 ± 2.05 m/s, *P* \< 0.0001; 95% CI, −17.4 to −7.92). The average variations of MNCV in median nerve, ulnar nerve, peroneal nerve and tibial nerve were 22.0 ± 5.96%, 27.6 ± 11.9%, 25.9 ± 4.36%, 27.3 ± 4.30%, respectively (Table [3](#T3){ref-type="table"}). All cases that had SNCV at presentation had slower and significantly decreased SNCV compared with the normal value (35.3 ± 1.33 m/s vs. 47.7 ± 2.40 m/s, *P* \< 0.001; 95% CI −18.2 to −6.46). The average variations of SNCV in median nerve, ulnar nerve and sural nerve were 19.9 ± 8.24%, 25.2 ± 7.75%, and 23.2 ± 3.95%, respectively.

Distal latency was observed. All cases that had distal latency for median nerve and peroneal nerve had prolonged latency compared with the normal value, and mean changes were 84.5 ± 39.2% and 189 ± 176%, respectively. There was normal distal latency for the ulnar nerve in 2 cases ([@B11], [@B14]) and for tibial nerve in 1 case ([@B14]).

For the CMAP amplitude, all cases that had median nerve and peroneal nerve examination had reduced amplitude compared with normal values. Mean changes were 78.1 ± 5.68% and 71.4 ± 25.7%, respectively. However, the tibial nerve in 2 cases ([@B9]) and the ulnar nerve in 1 case had normal CMAP amplitude ([@B14]).

Most cases had reduced sensory nerve action potential (SNAP) amplitude, except 1 case in the median nerve ([@B15]) and 1 case in the sural nerve ([@B9]).

Brainstem auditory evoked potentials, visual evoked potentials, and somatosensory evoked potentials
---------------------------------------------------------------------------------------------------

Eight cases had detectable Brainstem auditory evoked potentials, with 6 had prolonged or loss of later waves ([@B5], [@B9], [@B10], [@B14], [@B21]) and 2 had the normal response ([@B13], [@B16]). Visual evoked potentials (VEP) were performed in 3 cases and all reported prolonged VEP ([@B5], [@B16]). Somatosensory evoked potentials (SEP) was performed in 2 cases and all reported prolonged SEP ([@B13], [@B14]).

Discussion {#s4}
==========

To the best of our knowledge, this is the first systematic investigation of electrophysiological features in CMTX1 with transient central nervous deficits. In the present study, we found that all cases had significant but variable degrees of slowed nerve conduction. The median MNCV was the most frequently detected and valuable parameter.

Onset of CMTX1 with transient central nervous system deficits occurs most often in early childhood ([@B4]). Typical features of CMTX1 disease may not be recognized until after presentation with central nervous system manifestations, such as recurrent and transient weakness, dysarthria, and dysphagia ([@B4]). CMTX1 is usually caused by mutation in the *GJB1* gene encoding the gap junction beta 1 protein connexin 32 (Cx 32) ([@B3]). Proposed mechanisms include loss of Cx32 function affecting the gap junctions in the myelin sheath and causing CMTX1 peripheral manifestations or gain of function affecting the central nervous system ([@B2]). The pathological mechanism by which *GJB1* mutations cause the CNS deficit in patients with CMTX1 is not well understood, but may involve a decrease in the number of functioning gap junctions between oligodendrocytes and astrocytes, disrupting gap junction communication and leading to abnormalities in the ability of these cells to regulate intercellular exchange of ions and small molecules ([@B2]). It is important to consider CMTX1 in previously healthy children who present with symptoms suggestive of recurrent or transient central nervous system deficits and to conduct thorough examination for features of CMT disease and electrophysiological testing ([@B4]).

Median MNCV can be a sensitive parameter to support the diagnosis of CMTX1 with transient central nervous system deficits. In the current study, NCVs at presentation were slower and characterized as intermediate (30--40 m/s) or mild (\>40 m/s) slowing in CMTX1 patients with transient central nervous system deficits. Transient paralysis in children may also represent a feature of mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS), ADEM, adrenoleukodystrophy, moya moya disease, and younger transient ischemic attack (TIA). Electrodiagnostic irregularities noted at presentation with central nervous system deficits are expected in a chronic hereditary motor and sensory neuropathy, as documented in the present analysis ([@B4]).

Uniform slowing of NCVs is suggestive of hereditary demyelinating neuropathy. So NCVs are valuable to separate demyelinating and axonal damage in CMTX1. Theoretically, CMTX1 is characterized by sensory-motor neuropathy with mixed axonal and demyelinating pathology. In the present study, electrophysiological findings during the episode of acute nervous system deficits showed a diffuse and symmetrical slowing of MNCV and SNCV consistent with demyelinating-type neuropathy ([@B6]). Reduced CMAP and SNAP amplitudes and prolonged distal latencies were also present. One month following the episode, the MNCV, SNCV, and distal latencies were unchanged, showing evidence of peripheral involvement during the chronic disease ([@B6]).

Prolonged brainstem auditory evoked potentials, VEP and SEP were found in most CMTX1 patients with transient central nervous deficits. It would be interesting to know the presence of subclinical alterations of the central white matter before the acute event.

Conclusions {#s5}
===========

This case series serves as a reminder that the differential diagnosis of acute lesions of cerebral white matter should include the possibility of CMTX disease. Electrophysiological examination might be helpful in the diagnosis of recurring and intermittent neurological deficits with white matter lesion and median MCV is a sensitive and valuable parameter.
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